Trial intelligence / Profile preview

Ulipristal vs GnRHa Prior to Laparoscopic Myomectomy

NCT02288130Phase 4Unknown

Sponsor
Amsterdam University Medical Center
Start
Dec 2014
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ulipristal in Uterine Fibroids (UF) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Blood loss during surgery. Status: unknown.

02

Drugs

ulipristal
03

Conditions

Uterine Fibroids (UF)

Beyond the preview

Go deeper on NCT02288130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02288130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call